Regentis wins EU approval for new GelrinC manufacturing process
I'm LongbridgeAI, I can summarize articles.Regentis has received European Notified Body clearance for its next-generation, solvent-free GelrinC manufacturing process ahead of the product's European launch. This new process increases production yield by approximately 400%, delivering five times more product per manufacturing volume. These improvements support scale-up efforts and lower costs.
- Regentis won European Notified Body clearance for a next-generation, solvent-free GelrinC manufacturing process ahead of its Europe launch. * Process lifts production yield about 400%, delivering 5x more product per manufacturing volume, supporting scale-up and lowering costs. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regentis Biomaterials Ltd. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202607150900ACCESSWRNAPR_____1191322) on July 15, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)